国内外慢性乙型肝炎管理指南推荐建议的比较

2021-07-07 首都医科大学附属北京天坛医院药学部 临床药物治疗杂志

为我国临床医师开展慢性乙型肝炎的治疗提供依据和借鉴。 

中文标题:

国内外慢性乙型肝炎管理指南推荐建议的比较

发布日期:

2021-07-07

简要介绍:

对美国肝病学会《慢性乙型肝炎的预防,诊断和治疗更新:AASLD 2018乙型肝炎指南》、欧洲肝病学会《EASL 2017乙型肝炎病毒感染管理临床实践指南》、亚太肝病学会《亚太地区乙型肝炎管理临床实践指南:2015年更新版》、世界卫生组织《慢性乙型肝炎感染者的预防,护理和治疗指南》以及中华医学会感染病学分会和肝病学分会联合发布的《慢性乙型肝炎防治指南(2019年版)》的推荐建议要点包括治疗目标、抗病毒治疗的判断标准、治疗药物推荐、治疗终点和疗程、治疗失败患者的管理、妊娠期妇女预防母婴传播这6个方面进行对比,为我国临床医师开展慢性乙型肝炎的治疗提供依据和借鉴。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=国内外慢性乙型肝炎管理指南推荐建议的比较.pdf)] GetToolGuiderByIdResponse(projectId=1, id=53ed91c002283665, title=国内外慢性乙型肝炎管理指南推荐建议的比较, enTitle=, guiderFrom=临床药物治疗杂志, authorId=0, author=, summary=为我国临床医师开展慢性乙型肝炎的治疗提供依据和借鉴。 , cover=https://img.medsci.cn/2021124/1638630165977_5579292.png, journalId=0, articlesId=null, associationId=2159, associationName=首都医科大学附属北京天坛医院药学部, associationIntro=首都医科大学附属北京天坛医院药学部, copyright=0, guiderPublishedTime=Wed Jul 07 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">对美国肝病学会《慢性乙型肝炎的预防,诊断和治疗更新:AASLD 2018乙型肝炎指南》、欧洲肝病学会《EASL 2017乙型肝炎病毒感染管理临床实践指南》、亚太肝病学会《亚太地区乙型肝炎管理临床实践指南:2015年更新版》、世界卫生组织《慢性乙型肝炎感染者的预防,护理和治疗指南》以及中华医学会感染病学分会和肝病学分会联合发布的《慢性乙型肝炎防治指南(2019年版)》的推荐建议要点包括治疗目标、抗病毒治疗的判断标准、治疗药物推荐、治疗终点和疗程、治疗失败患者的管理、妊娠期妇女预防母婴传播这6个方面进行对比,为我国临床医师开展慢性乙型肝炎的治疗提供依据和借鉴。&nbsp;</span></p>, tagList=[TagDto(tagId=2629, tagName=慢性乙型肝炎), TagDto(tagId=118708, tagName=病毒性肝炎组)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2629, guiderKeyword=慢性乙型肝炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=196252, appHits=293, showAppHits=0, pcHits=622, showPcHits=195949, likes=2, shares=30, comments=23, approvalStatus=1, publishedTime=Sat Dec 04 23:06:59 CST 2021, publishedTimeString=2021-07-07, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Dec 04 23:06:55 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 05:48:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=国内外慢性乙型肝炎管理指南推荐建议的比较.pdf)])
国内外慢性乙型肝炎管理指南推荐建议的比较.pdf
下载请点击:
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1233287, encodeId=29e9123328e67, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 21:34:50 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231679, encodeId=6f7c12316e947, content=总结得真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Sun Jul 10 20:33:50 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202223, encodeId=2f3b1202223ec, content=能够对三大指南进行横向对比不仅有助于对于疾病整体认识的提高,而且看到国内外在管理该病方面的不同,拓宽视野。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:22:49 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202222, encodeId=0bd2120222280, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:17:23 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082696, encodeId=e606108269602, content=<a href='/topic/show?id=7c4a1044385b' target=_blank style='color:#2F92EE;'>#不错#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104438, encryptionId=7c4a1044385b, topicName=不错)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:41:18 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-07-18 ms5000000740006324

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1233287, encodeId=29e9123328e67, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 21:34:50 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231679, encodeId=6f7c12316e947, content=总结得真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Sun Jul 10 20:33:50 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202223, encodeId=2f3b1202223ec, content=能够对三大指南进行横向对比不仅有助于对于疾病整体认识的提高,而且看到国内外在管理该病方面的不同,拓宽视野。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:22:49 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202222, encodeId=0bd2120222280, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:17:23 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082696, encodeId=e606108269602, content=<a href='/topic/show?id=7c4a1044385b' target=_blank style='color:#2F92EE;'>#不错#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104438, encryptionId=7c4a1044385b, topicName=不错)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:41:18 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-07-10 lichifeng

    总结得真不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1233287, encodeId=29e9123328e67, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 21:34:50 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231679, encodeId=6f7c12316e947, content=总结得真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Sun Jul 10 20:33:50 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202223, encodeId=2f3b1202223ec, content=能够对三大指南进行横向对比不仅有助于对于疾病整体认识的提高,而且看到国内外在管理该病方面的不同,拓宽视野。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:22:49 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202222, encodeId=0bd2120222280, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:17:23 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082696, encodeId=e606108269602, content=<a href='/topic/show?id=7c4a1044385b' target=_blank style='color:#2F92EE;'>#不错#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104438, encryptionId=7c4a1044385b, topicName=不错)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:41:18 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-03-13 ms7000001146456559

    能够对三大指南进行横向对比不仅有助于对于疾病整体认识的提高,而且看到国内外在管理该病方面的不同,拓宽视野。。。。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1233287, encodeId=29e9123328e67, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 21:34:50 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231679, encodeId=6f7c12316e947, content=总结得真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Sun Jul 10 20:33:50 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202223, encodeId=2f3b1202223ec, content=能够对三大指南进行横向对比不仅有助于对于疾病整体认识的提高,而且看到国内外在管理该病方面的不同,拓宽视野。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:22:49 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202222, encodeId=0bd2120222280, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:17:23 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082696, encodeId=e606108269602, content=<a href='/topic/show?id=7c4a1044385b' target=_blank style='color:#2F92EE;'>#不错#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104438, encryptionId=7c4a1044385b, topicName=不错)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:41:18 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-03-13 ms7000001146456559

    感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1233287, encodeId=29e9123328e67, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 21:34:50 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231679, encodeId=6f7c12316e947, content=总结得真不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Sun Jul 10 20:33:50 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202223, encodeId=2f3b1202223ec, content=能够对三大指南进行横向对比不仅有助于对于疾病整体认识的提高,而且看到国内外在管理该病方面的不同,拓宽视野。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:22:49 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202222, encodeId=0bd2120222280, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0685567248, createdName=ms7000001146456559, createdTime=Sun Mar 13 15:17:23 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082696, encodeId=e606108269602, content=<a href='/topic/show?id=7c4a1044385b' target=_blank style='color:#2F92EE;'>#不错#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104438, encryptionId=7c4a1044385b, topicName=不错)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:41:18 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

拓展阅读

美国慢性乙型肝炎感染的治疗规范:2015年更新版

美国肝病研究学会(AASLD,American Association for the Study of Liver Diseases) · 2016-06-02

2015 中国慢性乙型肝炎防治指南—— 特殊人群抗病毒治疗推荐意见解读

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2015-03-11

2015 中国慢性乙型肝炎防治指南解读

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-03-10

聚乙二醇干扰素α治疗慢性乙型肝炎专家共识

中国肝病科相关专家小组(统称) · 2017-09-30